These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies. Watts GF; Chan DC; Ooi EM; Nestel PJ; Beilin LJ; Barrett PH Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):877-82. PubMed ID: 16922825 [TBL] [Abstract][Full Text] [Related]
8. Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies. Chan DC; Watts GF Expert Opin Pharmacother; 2011 Jan; 12(1):13-30. PubMed ID: 20629587 [TBL] [Abstract][Full Text] [Related]
9. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies. Chan DC; Barrett PH; Watts GF Clin Biochem Rev; 2004 Feb; 25(1):31-48. PubMed ID: 18516204 [TBL] [Abstract][Full Text] [Related]
11. The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia. Chan DC; Barrett PH; Watts GF Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):369-85. PubMed ID: 24840265 [TBL] [Abstract][Full Text] [Related]
12. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
13. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Ikewaki K; Schaefer JR; Frischmann ME; Okubo K; Hosoya T; Mochizuki S; Dieplinger B; Trenkwalder E; Schweer H; Kronenberg F; Koenig P; Dieplinger H Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2615-22. PubMed ID: 16195474 [TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein as a key component in the prevention of premature atherosclerotic disease in the insulin resistance syndrome. Hansel B; Kontush A; Twickler MT Semin Vasc Med; 2004 May; 4(2):215-23. PubMed ID: 15478044 [TBL] [Abstract][Full Text] [Related]
15. An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor? Chan DC; Chen MM; Ooi EM; Watts GF Int J Clin Pract; 2008 May; 62(5):799-809. PubMed ID: 18201179 [TBL] [Abstract][Full Text] [Related]
16. Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles. Lundahl B; Skoglund-Andersson C; Caslake M; Bedford D; Stewart P; Hamsten A; Packard CJ; Karpe F Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E739-45. PubMed ID: 16291571 [TBL] [Abstract][Full Text] [Related]
18. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome. Ooi EM; Watts GF; Barrett PH; Chan DC; Clifton PM; Ji J; Nestel PJ Asia Pac J Clin Nutr; 2007; 16(4):624-31. PubMed ID: 18042521 [TBL] [Abstract][Full Text] [Related]
19. Adiponectin is an important determinant of apoA-I catabolism. Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896 [TBL] [Abstract][Full Text] [Related]
20. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Lara-Castro C; Fu Y; Chung BH; Garvey WT Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]